Guevoura Fund has increased its short position in Bibb Instruments to 1.11 percent of the capital, from the previous level in April of 1.05 percent, which at the time made it a public short seller. This is evident from Finansinspektionen's short-selling register. The company is the only public short seller in the medical technology company. In total, 1.7 percent of the capital is shorted in the company. Finansinspektionen requires that positions over 0.1 percent be reported and that short positions over 0.5 percent be made public.